Current Neuro-Oncology
Volume
24 Number 22
30 November 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 22, 30 November
Barciszewska
AM, Belter A, Gawrońska I, Giel-Pietraszuk M,
Naskręt-Barciszewska MZ.
Cross-reactivity
between histone demethylase inhibitor valproic acid and DNA
methylation in glioblastoma cell lines.
Front
Oncol. 2022 Nov 16;12:1033035∟.
doi: 10.3389/fonc.2022.1033035∟.
PMID: 36465345∟.
Laboratory investigation. ˍ
Shiney
TSS, Jerome SA.
An
Intelligent System to Enhance the Performance of Brain Tumor
Diagnosis from MR Images.
J
Digit Imaging. 2022 Nov 16∟.
doi: 10.1007/s10278-022-00715-7∟.
PMID: 36385675∟.
Laboratory investigation˰
ˍ
Gamboa
NT, Crabb B, Henson JC, Cole KL, Weaver BD, Karsy M, Jensen
RL.
High-grade
glioma imaging volumes and survival: a single-institution analysis
of 101 patients after resection using intraoperative MRI.
J
Neurooncol. 2022 Nov 17∟.
doi: 10.1007/s11060-022-04159-5∟.
PMID: 36394718∟.
Observational study. ˍ
Liau
LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran
DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD,
Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA,
Chaudary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J,
Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG,
Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL,
Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O,
Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L,
Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu
D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ,
Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ,
Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch
ML.
Association
of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With
Extension of Survival Among Patients With Newly Diagnosed and
Recurrent Glioblastoma: A Phase 3 Prospective Externally
Controlled Cohort Trial.
JAMA
Oncol. 2022 Nov 17∟.
doi: 10.1001/jamaoncol.2022.5370∟.
PMID: 36394838∟.
Interventional study. ˍ
Burdett
KB, Unruh D, Drumm M, Steffens A, Lamano JB, Judkins J, Schwartz
M, Javier R, Amidei C, Lipp ES, Peters KB, Lai A, Eldred BSC,
Heimberger AB, McCortney K, Scholtens DM, Horbinski C.
Determining
venous thromboembolism risk in patients with adult-type diffuse
glioma.
Blood.
2022 Nov 18, 2022:blood.2022017858∟.
doi: 10.1182/blood.2022017858∟.
PMID: 36399711∟.
Laboratory investigation˰ ˍ
Dean
JA, Tanguturi SK, Cagney D, Shin KY, Youssef G, Aizer A, Rahman R,
Hammoudeh L, Reardon D, Lee E, Dietrich J, Tamura K, Aoyagi M,
Wickersham L, Wen PY, Catalano P, Haas-Kogan D, Alexander BM,
Michor F.
Phase
I study of a novel glioblastoma radiation therapy schedule
exploiting cell-state plasticity.
Neuro
Oncol. 2022 Nov 19, 2022:noac253∟.
doi: 10.1093/neuonc/noac253∟.
PMID: 36402744∟.
Interventional study˰
ˍ
Chen
F, Chao M, Huang T, Guo S, Zhai Y, Wang Y, Wang N, Xie X, Wang L,
Ji P.
The
role of preoperative inflammatory markers in patients with central
nervous system tumors, focus on glioma.
Front
Oncol. 2022 Nov 22;12:1055783∟.
doi: 10.3389/fonc.2022.1055783∟.
PMID: 36483052∟.
Observational study. ˍ
Chen
J, Wang T, Liu W, Qiu H, Zhang N, Chen X, Ding X, Zhang
L.
Extended
adjuvant temozolomide in newly diagnosed glioblastoma: A
single-center retrospective study.
Front
Oncol. 2022 Nov 22;12:1000501∟.
doi: 10.3389/fonc.2022.1000501∟.
PMID: 36483042∟.
Observational study. ˍ
Chiba
K, Aihara Y, Oda Y, Fukui A, Tsuduki S, Saito T, Nitta M, Muragaki
Y, Kawamata T.
Photodynamic
therapy for malignant brain tumors in children and young
adolescents.
Front
Oncol. 2022 Nov 24;12:957267∟.
doi: 10.3389/fonc.2022.957267∟.
PMID: 36505805∟.
Interventional study. ˍ
Chen
L, Ma J, Zou Z, Liu H, Liu C, Gong S, Gao X, Liang G.
Clinical
characteristics and prognosis of patients with glioblastoma: A
review of survival analysis of 1674 patients based on SEER
database.
Medicine
(Baltimore). 2022 Nov 25;101(47):e32042∟.
doi: 10.1097/MD.0000000000032042∟.
PMID: 36451503∟.Observational
study. ˍ
Gerritsen
JKW, Zwarthoed RH, Kilgallon JL, Nawabi NL, Versyck G, Jessurun
CAC, Pruijn KP, Fisher FL, Larivière E, Solie L, Mekary RA,
Satoer DD, Schouten JW, Bos EM, Kloet A, Nandoe Tewarie R, Smith
TR, Dirven CMF, De Vleeschouwer S, Vincent AJPE, Broekman
MLD.
Impact
of maximal extent of resection on postoperative deficits, patient
functioning and survival within clinically important glioblastoma
subgroups.
Neuro
Oncol. 2022 Nov 24, 2022:noac255∟.
doi: 10.1093/neuonc/noac255∟.
PMID: 36420703∟.
Observational study. ˍ
Escobar-Vidarte
OA, Griswold DP, Orozco-Mera J, Mier-Garcia JF, Peralta Pizza F.
A
Case Series of Stereotactic Biopsy of Brainstem Lesions through
the Transfrontal Approach.
J
Neurol Surg Rep. 2022 Nov 25;83(4):e123-e128∟.
doi: 10.1055/s-0042-1758696∟.
PMID: 36467870∟.
Case report. ˍ
Gao
Q, Zhou H, Wang G, Ma Z, Li J, Wang H, Sun G, Xue X.
A
Model for Predicting Clinical Prognosis in Patients with WHO Grade
2 Glioma.
J
Oncol. 2022 Nov 26;2022:2795939∟.
doi: 10.1155/2022/2795939∟.
PMID: 36471886∟.
Observational study. ˍ
Zhang
B, Wan W, Li Z, Gao Z, Ji N, Xie J, Wang J, Wang B, Lai-Wan Kwong
D, Guan X, Gao S, Zhao Y, Lu Y, Zhang L, Rodland KD, Tsang SX.
A
prognostic risk model for glioma patients by systematic evaluation
of genomic variations.
iScience.
2022 Nov 26;25(12):105681∟.
doi: 10.1016/j.isci.2022.105681∟.
PMID: 36536675∟.
Observational study. ˍ
Pokhylevych H, Khose S, Amer A,
Alhasan H, Kaya D, Johnson R, Fuller G, Gruschkus SK, Zaky W,
Weinberg JS, Johnson JM.
Retrospective
Analysis of Imaging Characteristics of Tectal Gliomas.
J
Comput Assist Tomogr. 2022 Nov 27∟.
doi: 10.1097/RCT.0000000000001391∟.
PMID: 36598462∟.
Observational study. ˍ
Peters
S, Frisch S, Stock A, Merta J, Bäumer C, Blase C, Schuermann
E, Tippelt S, Bison B, Frühwald M, Rutkowski S, Fleischhack
G, Timmermann B.
Proton
Beam Therapy for Pediatric Tumors of the Central Nervous
System-Experiences of Clinical Outcome and Feasibility from the
KiProReg Study.
Cancers
(Basel). 2022 Nov 28;14(23):5863∟.
doi: 10.3390/cancers14235863∟.
PMID: 36497345∟.
Observational study. ˍ
Topkan
E, Kucuk A, Selek U.
Pretreatment
Pan-Immune-Inflammation Value Efficiently Predicts Survival
Outcomes in Glioblastoma Multiforme Patients Receiving
Radiotherapy and Temozolomide.
J
Immunol Res. 2022 Nov 28;2022:1346094∟.
doi: 10.1155/2022/1346094∟.
PMID: 36479136∟.
Observational study. ˍ